Phase 1 trial of COVID-19 antibody drug begins

Phase 1 trial of COVID-19 antibody drug begins: US Pharma company Eli Lilly has started dosing participants in the Phase I clinical trial of antibody therapy to treat coronavirus. This is said to be the world’s first study to assess an antibody treatment for the disease.

Comments

Popular posts from this blog

Panasonic India to Launch Eluga Series of Smartphones

Intex launches Aquq Octa Smartphone